Olink Holding AB (OLK)
23.95
-0.06
(-0.25%)
USD |
NASDAQ |
May 16, 16:00
23.94
-0.01
(-0.04%)
After-Hours: 20:00
Olink Profit Margin (Quarterly): -55.87% for March 31, 2024
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | -55.87% |
| December 31, 2023 | -11.01% |
| September 30, 2023 | -4.12% |
| June 30, 2023 | -28.11% |
| March 31, 2023 | -50.84% |
| December 31, 2022 | 9.38% |
| September 30, 2022 | -4.05% |
| June 30, 2022 | -17.53% |
| March 31, 2022 | -53.67% |
| Date | Value |
|---|---|
| December 31, 2021 | -18.25% |
| September 30, 2021 | -27.39% |
| June 30, 2021 | -59.93% |
| March 31, 2021 | -104.9% |
| December 31, 2020 | 23.87% |
| September 30, 2020 | -0.95% |
| June 30, 2020 | -25.96% |
| March 31, 2020 | -139.0% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-139.0%
Minimum
Mar 2020
23.87%
Maximum
Dec 2020
-33.43%
Average
-25.96%
Median
Jun 2020
Profit Margin (Quarterly) Benchmarks
| Thermo Fisher Scientific Inc | 12.84% |
| Abliva AB | -18.42K% |
| Karolinska Development AB | 44.16% |
| Calliditas Therapeutics AB | -4.07% |
| Oncopeptides AB | -1.45K% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -7.01% |
| Return on Assets | -6.04% |
| Return on Invested Capital | -6.98% |
| Gross Profit Margin (Quarterly) | 60.68% |
| Operating Margin (Quarterly) | -86.75% |
| Return on Net Operating Assets | -6.27% |